Mediwound Ltd - ESG Rating & Company Profile powered by AI
Comprehensive ESG assessment of Mediwound Ltd are reached by signing in. This webpage displays a free E,S&G report for Mediwound Ltd. If you work at Mediwound Ltd and you wish to licence your ESG rating, please get in touch.
Mediwound Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.0; made up of an environmental score of 0.0, social score of 1.3 and governance score of 1.1.
1.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2499 | Zhejiang Jolly Pharmaceutical Co Ltd | 1.1 | Low |
| 2499 | Yunnan Baiyao Group Co Ltd | 1.1 | Low |
| 2549 | Mediwound Ltd | 1.0 | Low |
| 2549 | Benchmark Botanics Inc | 1.0 | Low |
| 2549 | HPGC Renmintongtai Pharmaceutical Corp | 1.0 | Low |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Mediwound Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Mediwound Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Mediwound Ltd report the average age of the workforce?
Sign up for free to unlockDoes Mediwound Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Mediwound Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Mediwound Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Mediwound Ltd offer flexible work?
Sign up for free to unlockDoes Mediwound Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Mediwound Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Mediwound Ltd conduct supply chain audits?
Sign up for free to unlockDoes Mediwound Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Mediwound Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Mediwound Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Mediwound Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Mediwound Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Mediwound Ltd disclose water use targets?
Sign up for free to unlockDoes Mediwound Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Mediwound Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Mediwound Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Mediwound Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Mediwound Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Mediwound Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Mediwound Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Mediwound Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Mediwound Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Mediwound Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Mediwound Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Mediwound Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Mediwound Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Mediwound Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Mediwound Ltd disclose its waste policy?
Sign up for free to unlockDoes Mediwound Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Mediwound Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Mediwound Ltd disclose energy use targets?
Sign up for free to unlockDoes Mediwound Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Mediwound Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Mediwound Ltd
These potential risks are based on the size, segment and geographies of the company.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.